Rafferty Asset Management
ELV icon

Rafferty Asset Management’s Elevance Health ELV Stock Holding History

Rafferty Asset Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.24M Buy
23,904
+6,849
+40% +$2.54M 0.02% 283
2026
Q1 		$4.99M Sell
17,055
-6,872
-29% -$2.26M 0.02% 356
2025
Q4 		$8.39M Sell
23,927
-1,074
-4% -$363K 0.03% 284
2025
Q3 		$8.08M Buy
25,001
+1,119
+5% +$348K 0.03% 324
2025
Q2 		$9.29M Buy
23,882
+2,409
+11% +$969K 0.03% 289
2025
Q1 		$9.34M Sell
21,473
-4,822
-18% -$1.94M 0.04% 273
2024
Q4 		$9.7M Buy
26,295
+2,775
+12% +$1.16M 0.03% 294
2024
Q3 		$12.2M Sell
23,520
-1,752
-7% -$936K 0.04% 247
2024
Q2 		$13.7M Buy
25,272
+1,018
+4% +$538K 0.05% 233
2024
Q1 		$12.6M Buy
24,254
+338
+1% +$168K 0.05% 224
2023
Q4 		$11.3M Sell
23,916
-677
-3% -$313K 0.05% 239
2023
Q3 		$10.7M Buy
24,593
+1,679
+7% +$762K 0.06% 212
2023
Q2 		$10.2M Buy
22,914
+1,532
+7% +$707K 0.06% 206
2023
Q1 		$9.83M Buy
21,382
+835
+4% +$397K 0.07% 186
2022
Q4 		$10.5M Buy
20,547
+7,699
+60% +$3.91M 0.09% 171
2022
Q3 		$5.84M Buy
12,848
+6,999
+120% +$3.35M 0.06% 301
2022
Q2 		$2.82M Sell
5,849
-1,570
-21% -$777K 0.03% 404
2022
Q1 		$3.64M Sell
7,419
-740
-9% -$338K 0.02% 454
2021
Q4 		$3.78M Buy
8,159
+385
+5% +$162K 0.02% 478
2021
Q3 		$2.9M Buy
7,774
+2,617
+51% +$995K 0.02% 497
2021
Q2 		$1.97M Buy
5,157
+395
+8% +$151K 0.01% 690
2021
Q1 		$1.71M Buy
4,762
+521
+12% +$168K 0.01% 662
2020
Q4 		$1.36M Sell
4,241
-376
-8% -$115K 0.01% 454
2020
Q3 		$1.24M Sell
4,617
-1,535
-25% -$413K 0.02% 545
2020
Q2 		$1.62M Buy
6,152
+3,781
+159% +$1.01M 0.02% 403
2020
Q1 		$538K Sell
2,371
-4,480
-65% -$1.22M 0.02% 318
2019
Q4 		$2.07M Buy
+6,851
New +$1.89M 0.03% 379
2015
Q3 		– Sell
-2,605
Closed -$428K – 567
2015
Q2 		$428K Buy
+2,605
New +$416K 0.03% 355

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rafferty Asset Management's ELV Position: Q2 2026 in Review

Rafferty Asset Management increased its Elevance Health (ELV) stake by 40% in Q2 2026, buying an estimated $2.54M and bringing the position to 23,904 shares worth $9.24M. The position accounts for 0.02% of the portfolio, ranked #283.

Rafferty Asset Management first reported a position in ELV in Q2 2015 and has held it in 28 quarters since. The position peaked at $13.7M in Q2 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Rafferty Asset Management held 23,904 shares of Elevance Health worth $9.24M as of Q2 2026.
  • Rafferty Asset Management bought 6,849 Elevance Health shares in Q2 2026, an estimated $2.54M.
  • Elevance Health made up 0.02% of Rafferty Asset Management's portfolio in Q2 2026, its #283 holding.
  • Rafferty Asset Management first reported a position in Elevance Health in Q2 2015 and has held it in 28 quarters since.
  • Rafferty Asset Management's Elevance Health position peaked at $13.7M in Q2 2024.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.